Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
OTC Chitosan Gel (ANX-011): A Nasal Gel Formulation for Cold and Flu Treatment that is Commercially Ready More
The Hu-PAC™ Platform: Delivering the Next Generation of Fully Human Therapeutic Antibodies More
Clinical Development of a Novel Vaccine Adjuvant and Delivery System: CAP (Calcium Phosphate) Nanoparticles More
The Lauriad® Drug Delivery Technology in Clinical Trials for the Treatment of Oropharyngeal Candidiasis, Labial Herpes and Cancer Pain More
pNL Luc AM Pseudotyping Vector: Producing High Titre Pseudooviruses from HIV More
Positive Top Line Results of a Clinical Trial of IFN-alpha-XL versus PegIntron™ in Patients with Chronic Hepatitis C Virus Infection More
AdVac® Technology: Manufacturing Platform for Vaccines More
Development of a Novel Treatment of Bedsores and Other Dermal Ulcers: A Spray Formulation Containing Recombinant Human Basic Fibroblast Growth Factor More
Antibodies against Human Kinase Proteins hBUB1A, hBUB1B, and hBUBR1 More
1G5 Cell Line for Quantitative and Qualitative Assays of HIV Infection, Related Functions and Inhibitory Treatments More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2010 - 414 pages - $690
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Feb 2009 - 242 pages - $690
Nov 2010 - 40 pages - $500
Apr 2010 - 5 pages - $500
Apr 2011 - 25 pages - $500
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us